Bromfenac Sodium
| Title | Journal |
|---|---|
| Topical bromfenac as an adjunctive treatment with intravitreal ranibizumab for exudative age-related macular degeneration. | Retina (Philadelphia, Pa.) 20121001 |
| Acute corneal melt associated with topical bromfenac use. | Eye & contact lens 20120701 |
| Prospective randomized controlled trial of combination ranibizumab (Lucentis) and bromfenac (Xibrom) for neovascular age-related macular degeneration: a pilot study. | Retina (Philadelphia, Pa.) 20120301 |
| A randomized comparison of to-aqueous penetration of ketorolac 0.45%, bromfenac 0.09% and nepafenac 0.1% in cataract patients undergoing phacoemulsification. | Current medical research and opinion 20111201 |
| Prostaglandin E2 inhibition of ketorolac 0.45%, bromfenac 0.09%, and nepafenac 0.1% in patients undergoing phacoemulsification. | Advances in therapy 20111201 |
| Inflammation after phakic implants. | Ophthalmology 20111201 |
| Safety and efficacy of bromfenac ophthalmic solution (Bromday) dosed once daily for postoperative ocular inflammation and pain. | Ophthalmology 20111101 |
| NSAIDs inhibit neovascularization of choroid through HO-1-dependent pathway. | Laboratory investigation; a journal of technical methods and pathology 20110901 |
| Once daily dosing of bromfenac ophthalmic solution 0.09% for postoperative ocular inflammation and pain. | Current medical research and opinion 20110901 |
| Ocular penetration and anti-inflammatory activity of ketorolac 0.45% and bromfenac 0.09% against lipopolysaccharide-induced inflammation. | Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20110401 |
| Pharmacokinetic comparisons of bromfenac in DuraSite and Xibrom. | Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20110201 |
| Efficacy of bromfenac sodium ophthalmic solution in preventing cystoid macular oedema after cataract surgery in patients with diabetes. | Acta ophthalmologica 20101201 |
| Efficacy and safety of bromfenac for the treatment of corneal ulcer pain. | Advances in therapy 20101001 |
| NSAIDs in combination therapy for the treatment of chronic pseudophakic cystoid macular edema. | Retina (Philadelphia, Pa.) 20100201 |
| Ophthalmic utility of topical bromfenac, a twice-daily nonsteroidal anti-inflammatory agent. | Expert opinion on pharmacotherapy 20091001 |
| Differential effects of non-steroidal anti-inflammatory drugs on mitochondrial dysfunction during oxidative stress. | Archives of biochemistry and biophysics 20091001 |
| Vitreous nonsteroidal antiinflammatory drug concentrations and prostaglandin E2 levels in vitrectomy patients treated with ketorolac 0.4%, bromfenac 0.09%, and nepafenac 0.1%. | Retina (Philadelphia, Pa.) 20091001 |
| Efficacy of ophthalmic nonsteroidal antiinflammatory drugs in suppressing anterior capsule contraction and secondary posterior capsule opacification. | Journal of cataract and refractive surgery 20090901 |
| Concentration and dosing of ketorolac versus bromfenac. | Journal of cataract and refractive surgery 20090701 |
| Comparison of efficacy of bromfenac sodium 0.1% ophthalmic solution and fluorometholone 0.02% ophthalmic suspension for the treatment of allergic conjunctivitis. | Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20090601 |
| Aqueous prostaglandin E(2) of cataract patients at trough ketorolac and bromfenac levels after 2 days dosing. | Advances in therapy 20090601 |
| Effect of bromfenac ophthalmic solution on ocular inflammation following cataract surgery. | Acta ophthalmologica 20090501 |
| Cyclooxygenase (COX)-inhibiting drug reduces HSV-1 reactivation in the mouse eye model. | Current eye research 20090301 |
| Topical bromfenac 0.09% vs. ketorolac 0.4% for the control of pain, photophobia, and discomfort following PRK. | Journal of refractive surgery (Thorofare, N.J. : 1995) 20090201 |
| Retrospective review of the efficacy of topical bromfenac (0.09%) as an adjunctive therapy for patients with neovascular age-related macular degeneration. | Retina (Philadelphia, Pa.) 20090101 |
| Ocular pharmacokinetics of a single dose of bromfenac sodium ophthalmic solution 0.1% in human aqueous humor. | Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20081201 |
| Comparison of ketorolac 0.4% and bromfenac 0.09% at trough dosing: aqueous drug absorption and prostaglandin E2 levels. | Journal of cataract and refractive surgery 20080901 |
| Re: Pharmacokinetics and pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenac. | Journal of cataract and refractive surgery 20080801 |
| 24-hour evaluation of the ocular distribution of (14)C-labeled bromfenac following topical instillation into the eyes of New Zealand White rabbits. | Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20080801 |
| The systemic safety of bromfenac ophthalmic solution 0.09%. | Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20071201 |
| Bromfenac ophthalmic solution 0.09% (Xibrom) for postoperative ocular pain and inflammation. | Ophthalmology 20070901 |
| In vivo pharmacokinetics and in vitro pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenac. | Journal of cataract and refractive surgery 20070901 |
| Corneal melting and perforation in Stevens Johnson syndrome following topical bromfenac use. | Journal of cataract and refractive surgery 20070901 |
| Effect of ophthalmic solution components on acrylic intraocular lenses. | Journal of cataract and refractive surgery 20070101 |
| Topical bromfenac sodium for long-term management of vernal keratoconjunctivitis. | Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde 20070101 |
| Effects of nonsteroidal ophthalmic drops on epithelial healing and pain in patients undergoing bilateral photorefractive keratectomy (PRK). | Advances in therapy 20070101 |
| Misuse and abuse of topically applied nonsteroidal anti-inflammatory drugs. | Cornea 20061201 |
| Three cases of corneal melting after instillation of a new nonsteroidal anti-inflammatory drug. | Cornea 20061201 |
| Hepatic disorders in patients treated with COX-2 selective inhibitors or nonselective NSAIDs: a case/noncase analysis of spontaneous reports. | Clinical therapeutics 20060801 |
| Effects of an opioid (oxycodone/paracetamol) and an NSAID (bromfenac) on driving ability, memory functioning, psychomotor performance, pupil size, and mood. | The Clinical journal of pain 20060601 |
| Comparison of cyclooxygenase inhibitory activity and ocular anti-inflammatory effects of ketorolac tromethamine and bromfenac sodium. | Current medical research and opinion 20060601 |
| A systematic review of NSAIDs withdrawn from the market due to hepatotoxicity: lessons learned from the bromfenac experience. | Pharmacoepidemiology and drug safety 20060401 |
| Hy's law: predicting serious hepatotoxicity. | Pharmacoepidemiology and drug safety 20060401 |
| How can 'Hy's law' help the clinician? | Pharmacoepidemiology and drug safety 20060401 |
| Three cases of corneal melting after instillation of a new nonsteroidal anti-inflammatory drug. | Cornea 20060201 |
| Global experience with Xibrom (bromfenac ophthalmic solution) 0.09%: the first twice-daily ophthalmic nonsteroidal anti-inflammatory drug. | International ophthalmology clinics 20060101 |
| New drugs and dosage forms. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20050501 |
| Comparison of 0.1% bromfenac sodium and 0.1% pemirolast potassium for the treatment of allergic conjunctivitis. | Japanese journal of ophthalmology 20040101 |
| Effects of nonsteroidal anti-inflammatory drugs on experimental allergic conjunctivitis in Guinea pigs. | Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20031201 |
| Drug-induced hepatotoxicity. | The New England journal of medicine 20030731 |
| Effect of non-steroidal anti-inflammatory ophthalmic solution on intraocular pressure reduction by latanoprost. | The British journal of ophthalmology 20030301 |
| Serious liver injury. Leading reason for drug removals, restrictions. | FDA consumer 20010101 |
| Structure toxicity relationships--how useful are they in predicting toxicities of new drugs? | Advances in experimental medicine and biology 20010101 |
| Bromfenac (Duract)-associated hepatic failure requiring liver transplantation. | The American journal of gastroenterology 19990801 |